Valeant pays $13m in royalty settlement

02-11-2017

Valeant pays $13m in royalty settlement

jansucko / iStockphoto.com

Canada-based Valeant has agreed to pay $13 million to biotechnology company PDL BioPharma to settle a dispute over royalties. 


Valeant, settlement, royalties, PDL BioPharma, patent, biotechnology, Neos Therapeutics, Depomed, diabetes


LSIPR